GALLANT 8 Tesaglitazar Add-on to Metformin

Clinical trial NCT00251953 · TERMINATED

Trial details

NCT number: NCT00251953
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2004-07-01
Enrollment: 555

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.